Immunitybio to participate in 34th annual piper sandler healthcare conference

Culver city, calif.--( business wire )--immunitybio, inc. (nasdaq: ibrx), a clinical-stage immunotherapy company, announced today that the company will be participating in the 34th annual piper sandler healthcare conference, which is taking place in new york city, november 29 - december 1, 2022.
IBRX Ratings Summary
IBRX Quant Ranking